Trial Profile
Use of Intravitreal JETREA in clinical practice: A European prospective Drug Utilisation Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Eye disorders; Retinal disorders
- Focus Therapeutic Use
- Acronyms TULIP
- 02 Sep 2019 According to an Oxurion media release, data from the study will be presented at the 19th European Society of Retina Specialists (EURETINA) 2019 Congress.
- 13 Jan 2015 New trial record